Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Did Riskified (NYSE:RSKD) Soar 22.29% on a Third Quarter Beat and Raised 2026 Forecast?

Key HighlightsRiskified (NYSE:RSKD) closed up 22.29% on November 11, 2026, after reporting third quarter results before the open.Revenue grew 41% to USD 115.2 million, accelerating from 22% in the second quarter, and adjusted EBITDA rose 47% to USD 8.1 million.The company raised 2026Revenueguidance to …

Vinay Lochav | 12 November 2026

What Sank Dominari Holdings (NASDAQ:DOMH) Revenue 69% to USD 16.4 Million in One Quarter?

Key HighlightsTotalRevenuefor the third quarter ended September 30, 2026 was USD 16.4 million, down about 69% from USD 52.4 million in the same quarter of 2025, as fewer deals closed.Net loss attributable to common stockholders was USD 1.9 million, or USD 0.08 per share, …

Vinay Lochav | 12 November 2026

Top 4 Late-Stage Biopharma Stocks Reporting on November 13, 2026: Helus Pharma (NASDAQ:HELP) EPS Estimate -1.01, Tevogen Inc. (NASDAQ:TVGN) EPS Estimate -2.5, TuHURA Biosciences (NASDAQ:HURA) EPS Estimate -0.13, Milestone Pharma (NASDAQ:MIST) EPS Estimate -0.21

Key Highlights1.01 is the loss per share expected for Helus Pharma per the screener snapshot, versus losses of 2.5 at Tevogen, 0.13 at TuHURA and 0.21 at Milestone, with call times not confirmed in the snapshot.686.12 million is the USD marketCapitalizationof Helus Pharma per …

Vinay Lochav | 12 November 2026

Why Did Azenta (NASDAQ:AZTA) Soar 20.8% on Its Fiscal 2027 Outlook?

Key HighlightsAzenta (NASDAQ:AZTA) closed up 20.80% on November 11, 2026, after reporting fiscal fourth quarter results on November 10.Revenue rose 5% to USD 167 million and adjustedEarningsreached USD 0.28 per share against USD 0.21 a year earlier.Fiscal 2027Revenueguidance is USD 648 million to USD …

Vinay Lochav | 12 November 2026

Why Did Datacentrex (NASDAQ:DTCX) Post a USD 2.6 Million Loss as Third-Quarter Revenue Fell 29%?

Key HighlightsThird-quarterRevenueat Datacentrex was USD 1,736,681, down about 29% from USD 2,449,482 a year earlier, while cost of revenue rose to USD 1,657,145 from USD 998,496, leavingGross Profitof only USD 79,536.The net loss widened to USD 2,608,602 for the three months ended September 30, …

Vinay Lochav | 12 November 2026

Top 4 Micro-Cap Therapeutics Stocks Reporting on November 13, 2026: Tvardi (NASDAQ:TVRD) EPS Estimate -0.57, Vistagen Therapeutics (NASDAQ:VTGN) EPS Estimate -0.37, Jaguar Health (NASDAQ:JAGX) EPS Estimate -614.25, Biofrontera (NASDAQ:BFRI) EPS Estimate -0.11

Key Highlights614.25 is the unusual loss per share estimate in the screener snapshot for Jaguar Health, versus losses of 0.57 at Tvardi, 0.37 at Vistagen and 0.11 at Biofrontera, a gap flagged as unexplained.6.44 million is the USD marketCapitalizationof Jaguar Health per the screener …

Vinay Lochav | 12 November 2026

Why Did Resideo (NYSE:REZI) Jump 18% After Its First Quarter as a Standalone Company?

Key HighlightsResideo (NYSE:REZI) shares rose 18.25% on November 11, 2026, placing it among the biggest gainers of the session, after third-quarter results beat on bothEarningsand revenue.Revenue reached USD 727 million, up 3% from a year earlier, while sales excluding the shrinking OEM security line …

Vinay Lochav | 12 November 2026

Why Did EuroDry (NASDAQ:EDRY) Earn USD 2.39 a Share After Posting a Loss a Year Earlier?

The company is a dry bulk owner whose vessels carry cargoes such as grain and minerals, and it employs nearly all of them in the spot market. Four ships are on index-linked charters tied to the Baltic Supramax index, and one is on a …

Vinay Lochav | 12 November 2026

Top 4 Healthcare Devices and Services Stocks Reporting on November 13, 2026: SBC Medical Group (NASDAQ:SBC) EPS Estimate 0.12, Owlet, Inc. (NYSE:OWLT) No EPS Estimate, Lifeward (NASDAQ:LFWD) EPS Estimate -1.04, PAVmed Inc. (NASDAQ:PAVM) EPS Estimate -0.66

Key Highlights0.12 is the consensus EPS estimate per the screener snapshot for SBC Medical Group, versus losses of 1.04 per share at Lifeward and 0.66 at PAVmed, while Owlet has no EPS estimate in the snapshot.538.92 million is the USD marketCapitalizationof SBC Medical Group …

Vinay Lochav | 12 November 2026

Why Did Sonos (NASDAQ:SONO) Jump 12.9% After Its Fiscal Fourth Quarter?

TheMarginline deserves a closer look. Adjusted gross margin slipped to 42.1% from 45.1% a year earlier, and the company pointed to higher memory chip costs, a pressure that has spread across consumer electronics as artificial intelligence data centres absorb supply. GAAP gross margin was …

Vinay Lochav | 12 November 2026
Support

Hi! How can we help you today?

Loading…